Literature DB >> 8202519

Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer.

G Bepler1, M A Garcia-Blanco.   

Abstract

Non-small-cell lung cancer is the leading cause of cancer death for men and women in the industrialized nations. Identification of regions for genes involved in its pathogenesis has been difficult. Data presented here show three distinct regions identified on chromosome 11p. Two regions on 11p13 distal to the Wilms tumor gene WT1 and on 11p15.5 between the markers HBB and D11S860 are described. The third region on the telomere of 11p15.5 has been previously described and is further delineated in this communication. By high-resolution mapping the size of each of these regions was estimated to be 2-3 megabases. The frequency of somatic loss of genetic information in these regions (57%, 71%, and 45%, respectively) was comparable to that seen in heritable tumors such as Wilms tumor (55%) and retinoblastoma (70%) and suggests their involvement in pathogenesis of non-small-cell lung cancer. Gene dosage analyses revealed duplication of the remaining allele in the majority of cases in the 11p13 and the proximal 11p15.5 region but rarely in the distal 11p15.5 region. In tumors with loss of heterozygosity in all three regions any combination of duplication or simple deletion was observed, suggesting that loss of heterozygosity occurs independently and perhaps at different points in time. These results provide a basis for studies directed at cloning potential tumor-suppressor genes in these regions and for assessing their biological and clinical significance in non-small-cell lung cancer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8202519      PMCID: PMC44026          DOI: 10.1073/pnas.91.12.5513

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer.

Authors:  D D'Amico; D P Carbone; B E Johnson; S J Meltzer; J D Minna
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

2.  Dinucleotide repeat polymorphism at the D11S860 locus.

Authors:  L A McNoe; M R Eccles; A E Reeve
Journal:  Nucleic Acids Res       Date:  1992-03-11       Impact factor: 16.971

3.  Isolation and chromosomal assignment of 100 highly informative human simple sequence repeat polymorphisms.

Authors:  T J Hudson; M Engelstein; M K Lee; E C Ho; M J Rubenfield; C P Adams; D E Housman; N C Dracopoli
Journal:  Genomics       Date:  1992-07       Impact factor: 5.736

4.  Nonrandom structural and numerical chromosome changes in non-small-cell lung cancer.

Authors:  J Whang-Peng; T Knutsen; A Gazdar; S M Steinberg; H Oie; I Linnoila; J Mulshine; M Nau; J D Minna
Journal:  Genes Chromosomes Cancer       Date:  1991-05       Impact factor: 5.006

5.  Cytogenetics of non-small cell lung cancer: analysis of consistent non-random abnormalities.

Authors:  R Lukeis; L Irving; M Garson; S Hasthorpe
Journal:  Genes Chromosomes Cancer       Date:  1990-07       Impact factor: 5.006

6.  Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer.

Authors:  M Emi; Y Fujiwara; T Nakajima; E Tsuchiya; H Tsuda; S Hirohashi; Y Maeda; K Tsuruta; M Miyaki; Y Nakamura
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

7.  Identification of a human chromosome 11 gene which is differentially regulated in tumorigenic and nontumorigenic somatic cell hybrids of HeLa cells.

Authors:  J H Lichy; W S Modi; H N Seuanez; P M Howley
Journal:  Cell Growth Differ       Date:  1992-08

8.  Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma and adenocarcinoma of the lung.

Authors:  S Yokoyama; K Yamakawa; E Tsuchiya; M Murata; S Sakiyama; Y Nakamura
Journal:  Cancer Res       Date:  1992-02-15       Impact factor: 12.701

9.  DNA typing and genetic mapping with trimeric and tetrameric tandem repeats.

Authors:  A Edwards; A Civitello; H A Hammond; C T Caskey
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

10.  Evidence for mendelian inheritance in the pathogenesis of lung cancer.

Authors:  T A Sellers; J E Bailey-Wilson; R C Elston; A F Wilson; G Z Elston; W L Ooi; H Rothschild
Journal:  J Natl Cancer Inst       Date:  1990-08-01       Impact factor: 13.506

View more
  21 in total

1.  A 7.5 Mb sequence-ready PAC contig and gene expression map of human chromosome 11p13-p14.1.

Authors:  B Gawin; A Niederführ; N Schumacher; H Hummerich; P F Little; M Gessler
Journal:  Genome Res       Date:  1999-11       Impact factor: 9.043

2.  Cloning, expression and localization of human BM88 shows that it maps to chromosome 11p15.5, a region implicated in Beckwith-Wiedemann syndrome and tumorigenesis.

Authors:  M Gaitanou; P Buanne; C Pappa; N Georgopoulou; A Mamalaki; F Tirone; R Matsas
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

3.  Polymorphisms in CARS are associated with gastric cancer risk: a two-stage case-control study in the Chinese population.

Authors:  Tian Tian; Ling Xiao; Jiangbo Du; Xun Zhu; Yayun Gu; Na Qin; Caiwang Yan; Li Liu; Hongxia Ma; Yue Jiang; Jiaping Chen; Hao Yu; Juncheng Dai
Journal:  Gastric Cancer       Date:  2017-04-13       Impact factor: 7.370

4.  PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1.

Authors:  Wendy Roeb; Antonia Boyer; Webster K Cavenee; Karen C Arden
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-06       Impact factor: 11.205

5.  CpG island clones for chromosome 11p--a resource for mapping and gene identification.

Authors:  C Thäte; J Pongratz; A König; B Klamt; S Tsaoussidou; M Higgins; T Shows; C Jones; M Gessler
Journal:  Mamm Genome       Date:  1995-06       Impact factor: 2.957

6.  An 84-kilobase physical map and repeat polymorphisms of the gastrin/cholecystokinin brain receptor region at the junction of chromosome segments 11p15.4 and 15.5.

Authors:  K C O'Briant; S Y Ali; H U Weier; G Bepler
Journal:  Chromosome Res       Date:  1998-08       Impact factor: 5.239

7.  Molecular genetic studies of chromosome 11 and chromosome 22q DNA sequences in pediatric medulloblastomas.

Authors:  S Lescop; A Lellouch-Tubiana; G Vassal; C Besnard-Guerin
Journal:  J Neurooncol       Date:  1999-09       Impact factor: 4.130

8.  Pharmacogenomics: a reality or still a promise?

Authors:  Gerold Bepler
Journal:  Lung Cancer       Date:  2006-10-24       Impact factor: 5.705

9.  Induction of the Tat-binding protein 1 gene accompanies the disabling of oncogenic erbB receptor tyrosine kinases.

Authors:  B W Park; D M O'Rourke; Q Wang; J G Davis; A Post; X Qian; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

10.  Rescue of targeted regions of mammalian chromosomes by in vivo recombination in yeast.

Authors:  N Kouprina; K Kawamoto; J C Barrett; V Larionov; M Koi
Journal:  Genome Res       Date:  1998-06       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.